Budgetary Impact of Treating Acute Promyelocytic Leukemia Patients with First-Line Arsenic Trioxide and Retinoic Acid from an Italian Payer Perspective

The objective of this study was to estimate the net cost of arsenic trioxide (ATO) added to all-trans retinoic acid (ATRA) compared to ATRA plus chemotherapy when used in first-line acute promyelocytic leukemia (APL) treatment for low to intermediate risk patients from the perspective of the overall...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Morgan, Wildner, Rebecca, Barnes, Gisoo, Martin, Monique, Mueller, Udo, Lo-Coco, Francesco, Pathak, Ashutosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534409/
https://www.ncbi.nlm.nih.gov/pubmed/26267454
http://dx.doi.org/10.1371/journal.pone.0134587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534409/
https://www.ncbi.nlm.nih.gov/pubmed/26267454
http://dx.doi.org/10.1371/journal.pone.0134587

Ejemplares similares